These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6362203)

  • 41. [Periodic application of topical corticosteroids. Practicability and therapeutic value in daily practice].
    Schmitz H; Flinzer E
    Derm Beruf Umwelt; 1982; 30(5):153-8. PubMed ID: 6818014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasis.
    Kosari P; Feldman SR
    Dermatol Online J; 2009 Mar; 15(3):15. PubMed ID: 19379659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A controlled clinical trial of the efficacy of topically applied fluocinonide in the treatment of recurrent aphthous ulceration.
    Pimlott SJ; Walker DM
    Br Dent J; 1983 Mar; 154(6):174-7. PubMed ID: 6342633
    [No Abstract]   [Full Text] [Related]  

  • 44. Therapy of resistant psoriasis with topical corticosteroids and dimethylsulfoxide.
    Kaidbey KH
    Dermatologica; 1976; 152(5):316-20. PubMed ID: 955230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
    Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
    Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distal phalangeal atrophy secondary to topical steroid therapy.
    Deffer TA; Goette DK
    Arch Dermatol; 1987 May; 123(5):571-2. PubMed ID: 3579338
    [No Abstract]   [Full Text] [Related]  

  • 47. Multicenter trial of fluocinonide in an emollient cream base.
    Fisher M; Kelly AP
    Int J Dermatol; 1979 Oct; 18(8):660-4. PubMed ID: 389843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous atrophy secondary to topical steroids.
    Hernández J; Rivera A; Sánchez JL
    Bol Asoc Med P R; 1984 May; 76(5):232-3. PubMed ID: 6590054
    [No Abstract]   [Full Text] [Related]  

  • 50. Topical steroids and UV radiation in psoriasis.
    Petrozzi JW
    Arch Dermatol; 1983 Mar; 119(3):207-10. PubMed ID: 6824358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment of lichen nitidus.
    Wright S
    Arch Dermatol; 1984 Feb; 120(2):155-6. PubMed ID: 6696468
    [No Abstract]   [Full Text] [Related]  

  • 52. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Steroid rosacea in children.
    Franco HL; Weston WL
    Pediatrics; 1979 Jul; 64(1):36-8. PubMed ID: 156343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic experiences with a new topical corticoid (Fluocinonid FAPG)].
    Eichenberger-de-Beer H
    Schweiz Rundsch Med Prax; 1972 Nov; 61(47):1465-7. PubMed ID: 4569846
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis.
    Yoon HS; Youn JI
    J Dermatolog Treat; 2007; 18(5):286-90. PubMed ID: 17852632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.
    Zakeri M; Valikhani M; Mortazavi H; Barzegari M
    Dermatol Online J; 2005 Dec; 11(3):5. PubMed ID: 16409901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
    Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
    Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluocinonide vs halcinonide in atopic dermatitis. A paired comparison of two potent topical corticosteroids.
    Silverman A
    Cutis; 1979 Mar; 23(3):375-8. PubMed ID: 369775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.